Oclaro was formed in 2009 by the merger of Bookham, Inc. and Avanex Corp. In its 2010 Annual Report, Oclaro states that the company has “750 U.S. patents and 293 non-U.S. patents” and that its “IP base represents significant investment in the optical industry over the past 20 years.” A check of the USPTO database shows that the company received 22 U.S. patents in 2010, and three so far in 2011, including the ’722 patent.
Those patents will be highly valuable in a sale of the company. I estimate if we get to 3-5$ we can get sold in the double digits. If we weather the 2-3 year optics blastoff we can see 20's based on the revenue growth and earning potential.
ochsnerbier...spare your own self. You have a completely wrong assumption. As if that assumpation had much to it. Is it overly difficult for you to speak to what was posted rather than going paranoid and accusing me of being some other poster?